11406911000001105: Ondansetron 4mg tablets (Almus Pharmaceuticals Ltd) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Ondansetron 4mg tablets (Almus Pharmaceuticals Ltd)
\UK product\Virtual medicinal product\Product containing precisely ondansetron (as ondansetron hydrochloride) 4 milligram/1 each conventional release oral tablet\Ondansetron 4mg tablets (Almus Pharmaceuticals Ltd)
\UK product\Virtual therapeutic moiety\Ondansetron\Product containing only ondansetron in oral dose form (medicinal product form)\Product containing precisely ondansetron (as ondansetron hydrochloride) 4 milligram/1 each conventional release oral tablet\Ondansetron 4mg tablets (Almus Pharmaceuticals Ltd)
\UK product\Virtual therapeutic moiety\Ondansetron\Product containing precisely ondansetron (as ondansetron hydrochloride) 4 milligram/1 each conventional release oral tablet\Ondansetron 4mg tablets (Almus Pharmaceuticals Ltd)

\Medicinal product\Medicinal product categorized by disposition\Product containing 5-hydroxytryptamine-3-receptor antagonist\Product containing ondansetron\Ondansetron\Product containing only ondansetron in oral dose form (medicinal product form)\Product containing precisely ondansetron (as ondansetron hydrochloride) 4 milligram/1 each conventional release oral tablet\Ondansetron 4mg tablets (Almus Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing 5-hydroxytryptamine-3-receptor antagonist\Product containing ondansetron\Ondansetron\Product containing precisely ondansetron (as ondansetron hydrochloride) 4 milligram/1 each conventional release oral tablet\Ondansetron 4mg tablets (Almus Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing 5-hydroxytryptamine-3-receptor antagonist\Product containing ondansetron\Product containing ondansetron in oral dose form (medicinal product form)\Product containing only ondansetron in oral dose form (medicinal product form)\Product containing precisely ondansetron (as ondansetron hydrochloride) 4 milligram/1 each conventional release oral tablet\Ondansetron 4mg tablets (Almus Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing ondansetron\Ondansetron\Product containing only ondansetron in oral dose form (medicinal product form)\Product containing precisely ondansetron (as ondansetron hydrochloride) 4 milligram/1 each conventional release oral tablet\Ondansetron 4mg tablets (Almus Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing ondansetron\Ondansetron\Product containing precisely ondansetron (as ondansetron hydrochloride) 4 milligram/1 each conventional release oral tablet\Ondansetron 4mg tablets (Almus Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing ondansetron\Product containing ondansetron in oral dose form (medicinal product form)\Product containing only ondansetron in oral dose form (medicinal product form)\Product containing precisely ondansetron (as ondansetron hydrochloride) 4 milligram/1 each conventional release oral tablet\Ondansetron 4mg tablets (Almus Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiemetic agent (product)\Product containing ondansetron\Ondansetron\Product containing only ondansetron in oral dose form (medicinal product form)\Product containing precisely ondansetron (as ondansetron hydrochloride) 4 milligram/1 each conventional release oral tablet\Ondansetron 4mg tablets (Almus Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiemetic agent (product)\Product containing ondansetron\Ondansetron\Product containing precisely ondansetron (as ondansetron hydrochloride) 4 milligram/1 each conventional release oral tablet\Ondansetron 4mg tablets (Almus Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiemetic agent (product)\Product containing ondansetron\Product containing ondansetron in oral dose form (medicinal product form)\Product containing only ondansetron in oral dose form (medicinal product form)\Product containing precisely ondansetron (as ondansetron hydrochloride) 4 milligram/1 each conventional release oral tablet\Ondansetron 4mg tablets (Almus Pharmaceuticals Ltd)
\Medicinal product\Product manufactured as oral dose form\Product containing ondansetron in oral dose form (medicinal product form)\Product containing only ondansetron in oral dose form (medicinal product form)\Product containing precisely ondansetron (as ondansetron hydrochloride) 4 milligram/1 each conventional release oral tablet\Ondansetron 4mg tablets (Almus Pharmaceuticals Ltd)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2007. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

40727101000001118 Ondansetron 4mg tablets (Almus Pharmaceuticals Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

40727201000001113 Ondansetron 4mg tablets (Almus Pharmaceuticals Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Ondansetron 4mg tablets (Almus Pharmaceuticals Ltd)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Ondansetron 4mg tablets (Almus Pharmaceuticals Ltd)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none	true	Inferred relationship	Existential restriction modifier
Ondansetron 4mg tablets (Almus Pharmaceuticals Ltd)	Is a	Product containing precisely ondansetron (as ondansetron hydrochloride) 4 milligram/1 each conventional release oral tablet	true	Inferred relationship	Existential restriction modifier
Ondansetron 4mg tablets (Almus Pharmaceuticals Ltd)	Has active ingredient	Ondansetron hydrochloride	false	Inferred relationship	Existential restriction modifier
Ondansetron 4mg tablets (Almus Pharmaceuticals Ltd)	Has active ingredient	Ondansetron	false	Inferred relationship	Existential restriction modifier
Ondansetron 4mg tablets (Almus Pharmaceuticals Ltd)	Has manufactured dose form	Tablet	false	Inferred relationship	Existential restriction modifier
Ondansetron 4mg tablets (Almus Pharmaceuticals Ltd)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Ondansetron 4mg tablets (Almus Pharmaceuticals Ltd)	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Ondansetron 4mg tablets (Almus Pharmaceuticals Ltd)	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier
Ondansetron 4mg tablets (Almus Pharmaceuticals Ltd)	Has NHS dm+d (dictionary of medicines and devices) basis of strength substance	Ondansetron	true	Inferred relationship	Existential restriction modifier
Ondansetron 4mg tablets (Almus Pharmaceuticals Ltd)	Has specific active ingredient	Ondansetron hydrochloride	true	Inferred relationship	Existential restriction modifier
Ondansetron 4mg tablets (Almus Pharmaceuticals Ltd)	Has dispensed dose form	Tablet	true	Inferred relationship	Existential restriction modifier
Ondansetron 4mg tablets (Almus Pharmaceuticals Ltd)	Has manufactured dose form	Conventional release oral tablet	true	Inferred relationship	Existential restriction modifier
Ondansetron 4mg tablets (Almus Pharmaceuticals Ltd)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier
Ondansetron 4mg tablets (Almus Pharmaceuticals Ltd)	Has basis of strength substance	Ondansetron	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Ondansetron 4mg tablets (Almus Pharmaceuticals Ltd) 30 tablet 3 x 10 tablets	Is pack of	False	Ondansetron 4mg tablets (Almus Pharmaceuticals Ltd)	Inferred relationship	Existential restriction modifier
Ondansetron 4mg tablets (Almus Pharmaceuticals Ltd) 30 tablet 3 x 10 tablets	Has AMP	True	Ondansetron 4mg tablets (Almus Pharmaceuticals Ltd)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
40727101000001118	Ondansetron 4mg tablets (Almus Pharmaceuticals Ltd) (product)	en	Fully specified name	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
40727201000001113	Ondansetron 4mg tablets (Almus Pharmaceuticals Ltd)	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module